Carrick Therapeutics Limited
4 clinical trials · Sponsor
◉ Watch Carrick Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies (NCT06600789) | Carrick Therapeutics Limited | 2024-08-16 |
| A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer (NCT05963997) | Carrick Therapeutics Limited | 2023-10-09 |
| Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies (NCT03363893) | Carrick Therapeutics Limited | 2017-11-14 |
Track Carrick Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.